Neuraptive Therapeutics, Inc. is a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries.
--(BUSINESS WIRE)-- Neuraptive Therapeutics, Inc. is a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries.
| Company: | Neuraptive Therapeutics, Inc. | ||
|
|
| ||
| Headquarters Address: | 2 Logan Square | ||
|
| Suite 1930 | ||
|
| Philadelphia, PA 19103 | ||
|
|
| ||
| Main Telephone: | 617-794-6442 | ||
|
|
| ||
| Website: | |||
|
|
| ||
| Type of Organization: | Private | ||
|
|
| ||
| Industry: | Biotechnology | ||
|
|
| ||
| Key Executives: | EVP, Head of R&D: Evan Tzanis | ||
|
|
| ||
| EVP, Head of R&D |
| ||
| Contact: | Evan Tzanis | ||
| Phone: | 617-794-6442 | ||
| Email: |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200428006022/en/
Source: Neuraptive Therapeutics, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20200428006022/en
